The presence and severity of diabetic retinopathy (DR) may contribute to the risk of falling in persons with diabetes, but evidence is currently equivocal.
A pproximately 1 of 3 community-living elderly people fall each year, with approximately 1 in 10 falls resulting in trauma or fracture. [1] [2] [3] [4] Even nontraumatic falls are detrimental to the quality of life and can result in a reduction in social and physical activities, physical decline, disability, loss of independence, institutionalization, and mortality. 5, 6 The health care cost of falls is substantial, particularly as the frequency and severity of falls increase. 7 Although falls have a multifactorial etiology, 8 people with diabetes are at increased risk of falls compared with those without the disease. [9] [10] [11] [12] [13] [14] However, the reasons behind the association are unclear, and it can be speculated that diabetic retinopathy (DR), a common and potentially blinding microvascular complication of diabetes, is an underlying risk factor. Left untreated, the proliferative stages of DR, together with diabetic macular edema, which can develop at any stage of DR, cause substantial and irreversible vision loss. 15 Several studies have found a clear association between glaucoma (which affects peripheral vision) or age-related macular degeneration (which affects central vision) and risk of falls. 16, 17 By contrast, previous investigations have found no significant association between DR and risk of falls, likely because of the limited number of DR cases in their population samples. 18 To our knowledge, no study has explicitly evaluated the associations of diabetes and the severity of DR with falls in a large population-based sample. However, understanding this association is crucial to inform the systematic development of evidence-based interventions to reduce falls in individuals with diabetes and DR. The purpose of this study was to investigate the independent associations of diabetes and the severity of DR with the likelihood of falling in a population-based study conducted in Singapore.
Methods

Study Population
The Singapore Epidemiology Eye Diseases (SEED) study is a population-based cohort study comprising 3 major ethnic groups, Malay (recruited from the Singapore Malay Eye Study), Indian (recruited from the Singapore Indian Eye Study), and Chinese (recruited from the Singapore Chinese Eye Study) individuals, with baseline assessments conducted from 2004 to 2011. Details of the SEED study design and methodology have been reported elsewhere. [19] [20] [21] In brief, the SEED study was conducted in the southwestern part of Singapore, using a standardized study protocol for all 3 ethnic groups. An agestratified random sampling strategy was used in each ethnic group to select adults aged 40 to 80 years. Ethnicities were defined by the Singapore census and indicated on the National Registration Identity Card. A total of 4168 Malay, 4497 Indian, and 4605 Chinese individuals were identified and invited to participate in the study. At the baseline visits conducted from 2004 to 2011, 10 033 participants underwent the study protocol examinations, including 3280 Malay, 3400 Indian, and 3353 Chinese persons, with a response rate of 78.7%, 75.6%, and 72.8%, respectively. The study was approved by the SingHealth Institutional Review Board. All participants gave informed written consent, and the conduct of the study adhered to the tenets of the Declaration of Helsinki.
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Assessment of Falls
Data on falls occurring within the previous year were selfreported and were gathered using a questionnaire administered by trained interviewers fluent in English, Mandarin, Malay, or Tamil (dependent on participant choice). During the clinic visit, participants were asked the following question: "In the past 12 months, have you fallen and landed on the floor or ground?" A fall was defined as having occurred when an individual who had been sitting or standing was suddenly and unintentionally on the ground.
Assessment of Covariates
The study was conducted at the research clinic of the Singapore Eye Research Institute. The protocol included a comprehensive, standardized examination as well as a questionnaire administered by interviewers trained to collect clinical and sociodemographic data, 19, 23 including educational level, income level, occupation, lifestyle factors (eg, smoking, alcohol consumption), self-reported family and medical history (eg, diabetes, hypertension, stroke, and cardiovascular disease), current medication, and insulin use. All clinical and questionnaire data were collected from participants during a single visit. Clinical covariates were obtained through the clinical examination conducted by trained and certified study optometrists (P.G. and R.M.). Presenting distance visual acuity (PVA) was determined monocularly using a logMAR vison chart at a distance of 4 m under standard lighting with the participant wearing refractive correction (if any). Visual impairment was defined as a logMAR score greater than 0.3 (a Snellen score <6/12) in the eye with the better vision. Measurements of systolic and diastolic blood pressures, obtained using an automatic blood pressure monitor (Dinamap Pro Series DP110X-RW; GE Medical Systems Information Technologies, Inc), height, weight, and body mass index (calculated as the weight in kilograms divided by the height in meters squared) were performed as per the SEED study protocol, which is described in detail elsewhere. 19, 20, 24 Nonfasting venous blood samples were also collected to assess levels of glucose, hemoglobin A 1c (HbA 1c ), serum creatinine, serum total cholesterol, high-density lipoprotein
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cholesterol, low-density lipoprotein cholesterol, and triglycerides. All samples were analyzed at the Singapore General Hospital Hematology Laboratory.
Two-field fundus images were obtained with a nonmydriatic fundus camera (CR-DGI; Canon) and graded for severity of DR using data from the worse eye with the modified Airlie House classification system by trained graders at the Singapore Eye Research Institute using the Early Treatment of Diabetic Retinopathy Study scale scores of none (10) (11) (12) (13) (14) (15) , minimal nonproliferative DR (NPDR) (20) , mild NPDR (35), moderate NPDR (43) (44) (45) (46) (47) , severe NPDR (53-60), and proliferative DR (61-85). 25 Vision-threatening diabetic retinopathy (VTDR) was defined using the Eye Diseases Prevalence Research Group definition as the presence of severe NPDR, proliferative DR, or clinically significant macular edema. 26 
Clinical Definitions of Ocular and Systemic Diseases
Glaucoma was defined using the scheme from the International Society of Geographic and Epidemiologic Ophthalmology 27 based on findings from gonioscopy, optic disc characteristics, and visual field results. Signs of age-related macular degeneration were graded using fundus photographs with the Wisconsin age-related maculopathy grading system. 28 Undercorrected refractive error was defined as the difference of at least 0.2 logMAR between PVA and the bestcorrected visual acuity in either eye. The presence of a cataract, including nuclear, cortical, or posterior subcapsular cataract, in either eye was based on Lens Opacities Classification System III grading. 29 Chronic kidney disease (CKD) was defined as having an estimated glomerular filtration rate less than 60 mL/min/1.73 m 2 . 30,31 Cardiovascular disease (CVD) was defined as a participant self-reported history of myocardial infarction, unstable angina pectoris, stroke, or transient ischemic attack. Diabetes was defined as a random glucose level of at least 200 mg/dL (to convert glucose to millimoles per liter, multiply by 0.0555), HbA 1c concentration of at least 6.5% of total hemoglobin (to convert HbA 1c to a proportion of total hemoglobin, multiply by 0.01), self-reported use of diabetic medication, or history of physician-diagnosed diabetes. 32 Hypertension was defined as having systolic blood pressure equal to or greater than 140 mm Hg, diastolic blood pressure equal to or greater than 90 mm Hg, or a self-reported history of hypertension or antihypertensive medication use. Polypharmacy was defined as taking 4 or more prescription medications. 33 
Statistical Analysis
All analyses were performed using Stata, version 14.1, for Windows (StataCorp) from January 1 through April 30, 2017. Characteristics of study participants who fell vs those who did not were compared using the τ 2 statistic for proportions for categorical variables and 2-tailed unpaired t tests for continuous variables. The Mann-Whitney test was performed when the distribution of a continuous variable was observed to be highly skewed. Multivariable logistic regression analysis was performed to determine whether having diabetes but no DR, or diabetes with DR, with reference to individuals with no diabetes, was independently associated with the likelihood of falling. In participants with diabetes, a trend analysis was conducted by treating DR severity as an ordinal variable, assigning equally spaced numeric values to each category (ie, no DR = 0, minimal DR = 1, mild DR = 2, moderate DR = 3, and VTDR = 4). This enabled the assessment of whether there was a linear pattern of increasing risk of falls with increasing DR severity. The adjusted variables included those participant characteristics found to be substantively different by fall status and hitherto known risk factors of falls in people with diabetes, including age, sex, systolic blood pressure, PVA in the better-seeing eye, ethnicity, polypharmacy, and the presence of CVD, CKD, or any eye disease (including cataract, glaucoma, age-related macular degeneration, and undercorrected refractive error). Analyses in patients with diabetes only was additionally adjusted for insulin use and duration of disease because these are established risk factors for DR and were found to have substantial differences by fall status in the present study. Interactions between ethnicity and diabetes with DR or diabetes in the absence of DR were determined by including multiplicative terms between primary effects of these variables in each model. Odds ratios (ORs) were reported with 95% CIs and P values. Twosided P values <.05 were considered statistically significant.
Results
Of the 10 033 participants in the SEED Study, 552 had missing data on diabetes, falls history, or other covariates or had ungradable fundus photographs and were thus excluded. were relatively older, were more likely to be women, had higher systolic blood pressure and HbA 1c levels, had a longer duration of diabetes, and were taking a greater number of prescription medications (polypharmacy). Furthermore, they were more likely to have diabetes, poorer PVA in the better-seeing eye, and comorbid conditions, such as CVD, CKD, and eye disease ( Table 1) .
In models adjusted for age and sex ( Table 2 , model 1) compared with participants with no diabetes, participants with diabetes alone (OR, 1.18; 95% CI, 1.02-1.35; P = .02) and those with diabetes and any severity of DR (OR, 1.54; 95% CI, 1.28-1.85; P < .001) had higher odds of falling. This association persisted in fully adjusted models for those with diabetes and any severity of DR (OR, 1.31; 95% CI, 1.07-1.60; P = .008). By contrast, participants with diabetes but without DR were not more likely than participants without diabetes to have fallen (OR, 1.06; 95% CI, 0.91-1.23; P = .42) (Table 2, model 2). When these 2 groups (ie, all individuals with diabetes, both with and without DR) were combined, no association was detected between the presence of diabetes and the odds of falling (OR, 1.13; 95% CI, 0.98-1.29; P = .07). There was no evidence that the observed associations differed depending on ethnicity (eTable in the Supplement). Table 3 gives the associations between DR severity and the odds of falling in participants with diabetes. In the fully adjusted model, among all DR severity levels, only participants with mild (OR, 1.81; 95% CI, 1.23-2.67; P = .003) and moderate (OR, 1.89; 95% CI, 1.16-3.07; P = .01) DR had higher odds of falling compared with participants with diabetes but without DR (model 2 and Figure) . Although no association was observed between VTDR and falls, a trend analysis showed a linear pattern of increasing risk of falls with increasing severity of DR (OR per level increase in DR severity, 1.10; 95% CI, 1.00-1.21; P for trend = .04).
In a subgroup analysis of Malay participants who had data on peripheral nerve function, we found no change in the significance of the association between DR and falls when we analyzed the model with (OR, 0.78; 95% CI, 0.46-1.32; P = .37) or without (OR, 1.20; 95% CI: 0.85-1.71; P = .29) peripheral neuropathy, which may be explained by the small sample size of participants (175) with DR in the Malay population.
Discussion
In this post hoc cross-sectional analysis of a multiethnic population-based study, diabetes per se was not associated with a higher risk of falling; the risk of falling among participants with diabetes but without DR was no different than that in participants without diabetes (OR, 1.06; 95% CI, 0.91-1.23; P = .42). However, the presence of DR in participants with diabetes was significantly associated with falling. Among persons with diabetes, those with mild and moderate NPDR were independently more likely to have a history of falls than those without DR. These findings were independent of key fall risk factors, including PVA, blood pressure, systemic disease, duration of diabetes, insulin use, polypharmacy, and concurrent eye disease. Our findings suggest that strategies to prevent or delay the development of DR are likely to reduce the risk of falls in persons with diabetes, preventing fall-related decline in physical functioning, suboptimal quality of life, and lack of independence in adults with diabetes. Furthermore, our results underscore the importance of safety and mobility training even for people with mild to moderate DR who are not experiencing visual impairment. Unlike previous studies that have reported that patients with diabetes are at higher risk of falling compared with those without diabetes, 11, 13, 14, 34, 35 we found no significant association between the presence of diabetes and risk of falling when we analyzed the population as a whole, without differentiating between participants with and without DR. Our results suggest that previously demonstrated associations between diabetes and risk of falls may have been driven by the presence of DR. This is an important finding, but further research is needed to confirm it. Our results suggested that adults with DR, particularly those with mild to moderate stages of the disease, had a higher risk of falling than those without DR, independent of PVA. Although falling has traditionally been linked with vision loss, 18, 36, 37 studies have shown that a reduction in the components of the aging visual function system, such as contrast sensitivity, stereo acuity, and color perception, is more strongly associated with poor postural stability and a greater capacity to bump into objects, leading to a greater risk of falling. [38] [39] [40] Given that components of aging visual function are compromised in DR, 41, 42 we speculate that this could explain the greater tendency to fall in patients with mild to moderate DR, independent of vision. Our results suggest that fall prevention efforts should be incorporated into the management of DR in patients, even those without existing visual impairment, to prevent serious injuries and loss of independence. Patients with VTDR were not associated with a higher likelihood of falling. This may be because we did not have sufficient power to determine this association. However, this lack of association may also be because these patients were more likely to be older (mean age, 62.7 vs 61.0 years) and have comorbidities (a greater proportion of them had hypertension, CVD, and CKD), which likely decreased their mobility and life space over time. This hypothesis is supported by studies showing that patients with severe DR have less muscle mass, 43 weaker muscle strength, 43 lower physical activity, 44 and increased fear of falling, mainly owing to balance and mobility impairment, 45 resulting in activity restriction, which may in turn reduce the risk of falls despite increased fall risk factors. However, because we did not collect data on these variables and, to our knowledge, no other studies have investigated the association between DR severity and falls, future longitudinal studies are needed to confirm our findings.
Strengths and Limitations
The strengths of our study include a large study sample characterized using a standardized clinical testing protocol, a high number of individuals with diabetes representing the spectrum of DR severity, and the objective categorization of DR using fundus photographs. In addition, comprehensive measurements were available on risk factors for falls that are also associated with DR, including duration of diabetes, insulin use, polypharmacy, blood pressure, vision, and presence of systemic diseases such as CVD and CKD.
The main limitation of our study is that falls were selfreported, and, as a result, our outcome may be subject to recall bias. 46 In addition, the cross-sectional nature of this study limited causal inferences. Further research using prospective and objective measures of falls, such as fall diaries, are required. Another limitation was the lack of information on the strength, balance, and gait components of mobility that have been linked to increased risk of falls. 12, 13 We did not account for physical inactivity or level of physical activity, although poor physical performance is associated with both decreased (due to activity restriction) 47 and increased risk of falling (probably through frailty and muscle weakness). 48 No data were captured on components of the aging visual system, such as contrast sensitivity, stereo acuity, and color perception, which may contribute to falls. Neither were data available on hypoglycemia, osteoporosis, hearing impairment, depression, or specific medications, such as antidepressants and β-blockers, all of which may contribute to falls or affect the recall of past falls. In addition, we did not adjust for peripheral neuropathy in our final model because these data were not captured for all 3 ethnic populations. Finally, because the study population comprised community-dwelling Asian persons with diabetes, our results may not apply to individuals who are institutionalized, belong to other ethnicities, or live in nonurbanized developing countries.
Conclusions
We found that diabetes per se was not a risk factor for falls; however, among individuals with diabetes, those with mild or moderate DR had a risk of falls nearly 2-fold as high as those without DR. Our findings suggest that efforts to prevent falls may need to be incorporated into the clinical care of individuals with diabetes, particularly those with early-stage DR. Subsequent longitudinal studies exploring the association between mild to moderate NPDR and falling are required to confirm our findings.
